Candel Therapeutics (CADL) Net Margin (2020 - 2022)
Candel Therapeutics recorded quarterly Net Margin of 25403.23% in Q4 2022, up 13.05% quarter-over-quarter from 29216.13% in Q3 2022, and up 10378011.0% year-over-year from N/an in Q4 2021.
Candel Therapeutics' Net Margin history runs 3 years deep, the most recent figure standing at 25403.23% for Q4 2022.
- In Q4 2022, Net Margin rose 10378011.0% year-over-year to 25403.23%; the TTM figure through Dec 2022 stood at 28395.97% (down 235657.0% YoY), while the FY2022 annual figure was 28169.6%, down 239060.0% from the prior year.
- Net Margin came in at 25403.23% for Q4 2022 at Candel Therapeutics, up from 29216.13% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 8145.16% in Q2 2020 to a low of 129183.33% in Q4 2021.
- A 3-year average of 30672.97% and a median of 25403.23% in 2022 frame the typical range for Net Margin.
- Across the five-year window, Net Margin sank 10958333 bps in 2021 and surged 10378011 bps in 2022, its largest moves.
- Candel Therapeutics' Net Margin stood at 19600.0% in 2020, then sank by 559 bps to 129183.33% in 2021, then surged by 80 bps to 25403.23% in 2022.
- According to Business Quant data, Net Margin over the past three periods registered 25403.23%, 29216.13%, and 29412.9% for Q4 2022, Q3 2022, and Q2 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Candel Therapeutics | 449.62 Mn | 449.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -25,403.23% |
| Sep 30, 2022 | -29,216.13% |
| Jun 30, 2022 | -29,412.90% |
| Mar 31, 2022 | -29,551.61% |
| Dec 31, 2021 | -129,183.33% |
| Sep 30, 2021 | -25,945.16% |
| Jun 30, 2021 | -17,148.39% |
| Mar 31, 2021 | -15,061.29% |
| Dec 31, 2020 | -19,600.00% |
| Sep 30, 2020 | -8,735.48% |
| Jun 30, 2020 | -8,145.16% |